跳转至内容
Merck
CN

1.06187

葡甲胺

EMPROVE® EXPERT, Ph. Eur., ChP, JP, USP

别名:

N -甲基- D -葡胺, 1-去氧-1-(甲胺)-D-山梨醇, 葡甲胺

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C7H17NO5
化学文摘社编号:
6284-40-8
分子量:
195.21
EC Index Number:
228-506-9
UNSPSC Code:
12352104
Beilstein/REAXYS Number:
385906
MDL number:
MFCD00004707

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

葡甲胺, EMPROVE® EXPERT, Ph. Eur., ChP, JP, USP

SMILES string

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI key

MBBZMMPHUWSWHV-BDVNFPICSA-N

InChI

1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1

agency

ChP
JP
Ph. Eur.
USP

product line

EMPROVE® EXPERT

form

solid

autoignition temp.

~662 °F

pH

11 (20 °C, 10 g/L in H2O)

bp

210 °C/1013 hPa

mp

129-131.5 °C (lit.)

application(s)

liquid formulation
pharmaceutical
solid formulation
solubility enhancement

storage temp.

no temp limit

Quality Level

500

正在寻找类似产品? 访问 产品对比指南

相关类别

Application

Meglumine Emprove® Essential is a robust pharmaceutical excipient that can provide stability, solubility enhancement and pH modification in solid and liquid formulations.

Features and Benefits

  • Solubility and bioavailability enhancement of APIs
  • Excellent counterion performance, a viable alternative to sodium
  • API grade: manufactured under the cGMP ICH Q7 guideline for APIs
  • Sole manufacturing location for API-grade meglumine in Europe
  • Multi-compendial product, complying with all major pharmacopeias, including ChP
  • Meglumine Emprove® API has also been successfully co-reviewed in China

General description

When working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and bioavailability limitations just to name a few. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Overcoming Excipient Risks and Challenges for Parenteral Formulations

This overview describes the challenges when developing parenteral formulations and strategies to overcome them and reduce the risk of production.

Liquid Formulation Solubility Enhancement

Discover strategies to enhance solubility in injectable formulations using excipients, including cyclodextrins, meglumine, and polyethylene glycols.

API Solubility and Dissolution Enhancement Via Formulation

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

Active Pharmaceutical Ingredient (API) Stability in Solid Dose Formulation

This article describes the use of excipients to help address API stability issues.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持